Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention

Background. A long-acting injectable formulation of rilpivirine (RPV), under investigation as antiretroviral pre-exposure prophylaxis (PrEP), may facilitate PrEP adherence. In contrast, cross-resistance between RPV and nonnucleoside reverse-transcriptase inhibitors comprising first-line antiretrovir...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Glaubius, Robert L., Parikh, Urvi M., Hood, Greg, Penrose, Kerri J., Bendavid, Eran, Mellors, John W., Abbas, Ume L.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Major Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5047428/
https://ncbi.nlm.nih.gov/pubmed/27703992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw125
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki